Medindia

X

RNA Sequencing: Technologies and Global Markets

Tuesday, June 7, 2016 General News J E 4
Advertisement

LONDON, June 6, 2016 /PRNewswire/ -- This BCC Research report provides an overview of the current and future states of the RNA Sequencing (RNA Seq) market for the years 2015, 2016 and 2020 in segments such as instruments, tools and reagents, data analysis, and services. Use this report to:Analyze various segments of the RNA-Sequencing market such as RNA-Sequencing tools and reagents, RNA-Sequencing data analysis, and RNA-Sequencing servicesIdentify the main factors affecting each segment and forecast their market growth, future trends and product developmentEvaluate infrastructure for the health and growth of the RNA-Sequencing market as a wholeHighlightsThe global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate CAGR) of 14.9%.The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8 million in 2015, a CAGR of 13.0%.The services segment should reach $460.5 million by 2020 from $170.5 million in 2015, a CAGR of 9.1%.STUDY GOALS AND OBJECTIVESThis BCC Research report, RNA Sequencing: Technologies and Global Markets, provides an overview of the current and future states of the RNA Sequencing (RNA-Seq) market for the years 2015, 2016 and 2020 in the following segments: instruments, tools and reagents, data analysis, and services. Special emphasis is placed on RNA-Seq technology development because RNA-Seq depends on the development of new and improved high throughput sequencing technologies. This report describes the available technologies and the major players currently working in the market, as well as detailed analysis of the competitive environments, including new or potential trends in research and product development. This report also includes information regarding opportunities and obstacles affecting this market and its different sectors.Each of the four RNA-Seq segments has healthy growth potential. Each of them also face serious and unique challenges. This report has a comprehensive discussion of technologies as well as the competitive landscape in the global market. It is designed to aim companies in their strategic planning efforts for exploiting RNA-Seq industry opportunities.REASONS FOR DOING THE STUDYRNA-Seq, introduced around 2010, is a method for transcriptomics. In a few short years, it has become the method of choice for transcriptome studies, rapidly replacing another transcriptomics method; the microarray. Transcriptomics is the study of transcriptome, the complete set of RNA transcripts that are produced by the genome, under specific circumstances or in a specific cell, using high-throughput methods.RNA-Seq not only provides benefits to the scientific research community, but also has huge clinical potential in diagnostics and drug discovery. The RNA-Seq industry is an emerging, evolving and important biomedical sector; a comprehensive and critical study about its technologies and markets is needed for better understanding.SCOPE AND FORMATThe geographic scope is global. The RNA-Seq market is complex, consisting of a number of different segments. The market segments are: RNA-Seq instruments; RNA-Seq tools and reagents; RNA-Seq data analysis and RNA-Seq services. Each segment is affected differently by technological and regulatory developments. Thisreport identifies the main factors affecting each segment and forecasts market growth, future trends and product development in every major market segment. Market forecasts are given for the years 2015, 2016 and 2020.The report is organized by presenting the core segment (sequencing instruments) first, followed by its derivative segments (tools and reagents, data analysis, services). The development of sequencing instruments is vital for RNA-Seq development; thus sequencing instruments segment is classified as the core segment. However, it doesnot suggest that the derivative segments are not important. In fact, the RNA-Seq instruments segment is neither the biggest nor the fastest growing among the four segments. The instruments segment, however, provides the infrastructure for the health and growth of the RNA-Seq market as a whole.Download the full report: https://www.reportbuyer.com/product/3688705/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com  Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rna-sequencing-technologies-and-global-markets-300280234.html

SOURCE ReportBuyer

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Osteosarcoma Global Clinical Trials Review, H1, 20...
S
Judge's Order Protects Dementia Patients at Saber ...